November 2016

Guipry, France and Sydney, Australia, 8 November 2016 - French biotechnology company, NG Biotech, and Australian medical device innovator, Atomo Diagnostics, announced today that they have developed the world’s first fully-integrated blood-based rapid test for detection of hCG levels in pregnancy. The new product, NG-Test®...

Written by John Kelly, CEO at Atomo Diagnostics Since its formation in 2010, Atomo has been making waves in the diagnostics technology space with  award-winning products. The company is also recognised by key global health partners for  supporting early diagnosis of HIV, as well as its...